Literature DB >> 27151081

The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS).

N Kanuri1, B Cassell1, S E Bruce2, K S White2, B M Gott3, C P Gyawali1, G S Sayuk4,5,6.   

Abstract

BACKGROUND: Irritable bowel syndrome (IBS) is a common abdominal pain disorder without an organic explanation. Abuse histories (physical, sexual, emotional) are prevalent in IBS. While abuse relates to mood disorders (depression and anxiety) also common in IBS, the influence of abuse on gastrointestinal (GI) symptoms and health-related quality of life (HRQOL) and its independence from psychological symptom comorbidity has not been studied.
METHODS: Consecutive GI outpatients completed the ROME III Research Diagnostic Questionnaire and questionnaires on trauma (Life-Stress Questionnaire), mood (Beck Depression/Anxiety Inventories), somatic symptoms (PHQ-12), and HRQOL (SF-36). Current GI symptom severity and bother were assessed using 10-cm Visual Analog Scales. KEY
RESULTS: 272 ROME-defined IBS (47.6 ± 0.9 years, 81% female) and 246 non-FGID (51.6 ± 1.0 years, 65% female) subjects participated. IBS patients reported greater rates of physical, sexual, and emotional abuse (p < 0.006 each), and higher depression, anxiety, and somatic symptoms (p < 0.001). Greater bowel symptom bother (7.4 ± 0.2 vs 6.7 ± 0.2, p = 0.040), severity (7.7 ± 0.2 vs 6.5 ± 0.2, p < 0.001), recent symptomatic days (9.8 ± 0.4 vs 8.5 ± 0.3, p = 0.02), and poorer HRQOL (40.9 ± 2.3 vs 55.5 ± 1.7, p < 0.001) were noted in IBS with abuse. Abuse effects were additive, with greater IBS symptom severity and poorer HRQOL noted in cases with multiple forms of abuse. Mediation analyses suggested that abuse effects on GI symptoms and HRQOL were partially mediated by mood. CONCLUSIONS & INFERENCES: Abuse experiences common among IBS sufferers are associated with reports of greater GI symptoms and poorer HRQOL, particularly in those with multiple forms of abuse; this relationship may be partially mediated by concomitant mood disturbances.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  abuse; depression; health-related quality of life; irritable bowel syndrome

Mesh:

Year:  2016        PMID: 27151081      PMCID: PMC5042818          DOI: 10.1111/nmo.12848

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  51 in total

1.  The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease.

Authors:  R C Spiller; D J Humes; E Campbell; M Hastings; K R Neal; G E Dukes; P J Whorwell
Journal:  Aliment Pharmacol Ther       Date:  2010-09       Impact factor: 8.171

2.  Selected symptoms associated with sexual and physical abuse history among female patients with gastrointestinal disorders: the impact on subsequent health care visits.

Authors:  J Leserman; Z Li; D A Drossman; Y J Hu
Journal:  Psychol Med       Date:  1998-03       Impact factor: 7.723

3.  Early life trauma predicts self-reported levels of depressive and anxiety symptoms in nonclinical community adults: relative contributions of early life stressor types and adult trauma exposure.

Authors:  Denise A Chu; Leanne M Williams; Anthony W F Harris; Richard A Bryant; Justine M Gatt
Journal:  J Psychiatr Res       Date:  2012-09-26       Impact factor: 4.791

4.  Early life stress and adult emotional experience: an international perspective.

Authors:  Ronald A Cohen; Brian L Hitsman; Robert H Paul; Jeanne McCaffery; Laura Stroud; Lawrence Sweet; John Gunstad; Raymond Niaura; Alexander MacFarlane; Richard A Bryant; Evian Gordon
Journal:  Int J Psychiatry Med       Date:  2006       Impact factor: 1.210

5.  Aftermath of sexual abuse history on adult patients suffering from chronic functional pain syndromes: an fMRI pilot study.

Authors:  Michael Noll-Hussong; Alexander Otti; Leonhard Laeer; Afra Wohlschlaeger; Claus Zimmer; Claas Lahmann; Peter Henningsen; Thomas Toelle; Harald Guendel
Journal:  J Psychosom Res       Date:  2010-03-16       Impact factor: 3.006

6.  Anger and childhood sexual abuse are independently associated with irritable bowel syndrome.

Authors:  Helen Beesley; Jonathan Rhodes; Peter Salmon
Journal:  Br J Health Psychol       Date:  2009-08-18

Review 7.  Childhood maltreatment and psychopathology: A case for ecophenotypic variants as clinically and neurobiologically distinct subtypes.

Authors:  Martin H Teicher; Jacqueline A Samson
Journal:  Am J Psychiatry       Date:  2013-10       Impact factor: 18.112

Review 8.  The link between childhood trauma and depression: insights from HPA axis studies in humans.

Authors:  Christine Heim; D Jeffrey Newport; Tanja Mletzko; Andrew H Miller; Charles B Nemeroff
Journal:  Psychoneuroendocrinology       Date:  2008-07       Impact factor: 4.905

Review 9.  Chronic opioid therapy for chronic non-cancer pain: a review and comparison of treatment guidelines.

Authors:  Chi Wai Cheung; Qiu Qiu; Siu-Wai Choi; Brendan Moore; Roger Goucke; Michael Irwin
Journal:  Pain Physician       Date:  2014 Sep-Oct       Impact factor: 4.965

10.  The impact of psychiatric and extraintestinal comorbidity on quality of life and bowel symptom burden in functional GI disorders.

Authors:  J Vu; V Kushnir; B Cassell; C P Gyawali; G S Sayuk
Journal:  Neurogastroenterol Motil       Date:  2014-07-29       Impact factor: 3.598

View more
  16 in total

1.  The impact of irritable bowel syndrome on daily functioning: Characterizing and understanding daily consequences of IBS.

Authors:  S Ballou; L Keefer
Journal:  Neurogastroenterol Motil       Date:  2016-10-25       Impact factor: 3.598

Review 2.  Functional Dyspepsia: Diagnostic and Therapeutic Approaches.

Authors:  Gregory S Sayuk; C Prakash Gyawali
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

3.  Acute and repeated exposure to social stress reduces gut microbiota diversity in Syrian hamsters.

Authors:  Katherine A Partrick; Benoit Chassaing; Linda Q Beach; Katharine E McCann; Andrew T Gewirtz; Kim L Huhman
Journal:  Behav Brain Res       Date:  2018-02-21       Impact factor: 3.332

4.  Risk and Protective Factors Related to Early Adverse Life Events in Irritable Bowel Syndrome.

Authors:  Tiffany Ju; Bruce D Naliboff; Wendy Shih; Angela P Presson; Cathy Liu; Arpana Gupta; Emeran A Mayer; Lin Chang
Journal:  J Clin Gastroenterol       Date:  2020-01       Impact factor: 3.174

Review 5.  The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis.

Authors:  Changhyun Lee; Eunyoung Doo; Ji Min Choi; Seung-Ho Jang; Han-Seung Ryu; Ju Yup Lee; Jung Hwan Oh; Jung Ho Park; Yong Sung Kim
Journal:  J Neurogastroenterol Motil       Date:  2017-07-30       Impact factor: 4.924

Review 6.  Mechanisms of Stress-induced Visceral Pain.

Authors:  Beverley Greenwood-Van Meerveld; Anthony C Johnson
Journal:  J Neurogastroenterol Motil       Date:  2018-01-30       Impact factor: 4.924

7.  A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-κB Signaling Pathways.

Authors:  Li Zeng; Kaixue Li; Hong Wei; Jingjing Hu; Lu Jiao; Shaoyong Yu; Ying Xiong
Journal:  Front Pharmacol       Date:  2018-03-27       Impact factor: 5.810

8.  Early weaning stress induces chronic functional diarrhea, intestinal barrier defects, and increased mast cell activity in a porcine model of early life adversity.

Authors:  C S Pohl; J E Medland; E Mackey; L L Edwards; K D Bagley; M P DeWilde; K J Williams; A J Moeser
Journal:  Neurogastroenterol Motil       Date:  2017-06-01       Impact factor: 3.598

Review 9.  Sex-Bias in Irritable Bowel Syndrome: Linking Steroids to the Gut-Brain Axis.

Authors:  Sik Yu So; Tor C Savidge
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-19       Impact factor: 5.555

10.  Fatty acid components in Asian female patients with irritable bowel syndrome.

Authors:  Chian Sem Chua; Shih-Yi Huang; Chiao-Wen Cheng; Chyi-Huey Bai; Chien-Yeh Hsu; Hung-Wen Chiu; Jung-Lung Hsu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.